Track the 셀비온 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 셀비온 has recorded 9 insider filings. Market capitalisation: €162.7bn. The latest transaction was reported on 15 May 2026 (Purchase). Among the most active insiders: 박재민. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
9 of 9 declarations
셀비온 是一家在 XKRX 市场上市的医疗保健和制药公司。它专注于为医疗领域开发创新解决方案。